In contrast, RSPO3 derived from myCAFs can up-regulate EGR1 expression in tumor cells, promoting the conversion of gastric cancer cells into the MP7 state and thereby enhancing the tumor’s invasiveness and drug resistance (160). This evidence concerns the gene RSPO3 and neoplasm.